Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 757 to 766 of 766 entries
Sorted by: Best Match Show Resources per page
To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanoma.

Cancer

Eskander A, Marqueen KE, Edwards HA, Joshua AM, Petrella TM, de Almeida JR, Goldstein DP, Ferket BS.
PMID: 33844296
Cancer. 2021 Jul 01;127(13):2333-2341. doi: 10.1002/cncr.33499. Epub 2021 Apr 12.

BACKGROUND: Tanning bed use is common among US adolescents, but is associated with increased melanoma risk. The decision to ban tanning bed use by adolescents should be made in consideration of the potential health benefits and costs.METHODS: The US...

Cite
Eskander A, Marqueen KE, Edwards HA, et al. To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanoma. Cancer. 2021;127(13):2333-2341doi: 10.1002/cncr.33499.
Eskander, A., Marqueen, K. E., Edwards, H. A., Joshua, A. M., Petrella, T. M., de Almeida, J. R., Goldstein, D. P., & Ferket, B. S. (2021). To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanoma. Cancer, 127(13), 2333-2341. https://doi.org/10.1002/cncr.33499
Eskander, Antoine, et al. "To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanoma." Cancer vol. 127,13 (2021): 2333-2341. doi: https://doi.org/10.1002/cncr.33499
Eskander A, Marqueen KE, Edwards HA, Joshua AM, Petrella TM, de Almeida JR, Goldstein DP, Ferket BS. To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanoma. Cancer. 2021 Jul 01;127(13):2333-2341. doi: 10.1002/cncr.33499. Epub 2021 Apr 12. PMID: 33844296.
Copy Download .nbib Format: NLM
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial.

EClinicalMedicine

Amin S, Mallick AA, Edwards H, Cortina-Borja M, Laugharne M, Likeman M, O'Callaghan FJK.
PMID: 33681737
EClinicalMedicine. 2021 Jan 14;32:100715. doi: 10.1016/j.eclinm.2020.100715. eCollection 2021 Feb.

BACKGROUND: Tuberous Sclerosis Complex (TSC) is a genetic disorder characterised by the development of benign tumours secondary to loss of inhibitory regulation of the mTOR (mechanistic Target of Rapamycin) intracellular growth pathway. Metformin inhibits the mTOR pathway. We investigated...

Cite
Amin S, Mallick AA, Edwards H, et al. The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial. EClinicalMedicine. 2021;32:100715doi: 10.1016/j.eclinm.2020.100715.
Amin, S., Mallick, A. A., Edwards, H., Cortina-Borja, M., Laugharne, M., Likeman, M., & O'Callaghan, F. J. K. (2021). The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial. EClinicalMedicine, 32100715. https://doi.org/10.1016/j.eclinm.2020.100715
Amin, Sam, et al. "The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial." EClinicalMedicine vol. 32 (2021): 100715. doi: https://doi.org/10.1016/j.eclinm.2020.100715
Amin S, Mallick AA, Edwards H, Cortina-Borja M, Laugharne M, Likeman M, O'Callaghan FJK. The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial. EClinicalMedicine. 2021 Jan 14;32:100715. doi: 10.1016/j.eclinm.2020.100715. eCollection 2021 Feb. PMID: 33681737; PMCID: PMC7910694.
Copy Download .nbib Format: NLM
Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis.

Journal of sport and health science

Edwards T, Michelsen AS, Fakolade AO, Dalgas U, Pilutti LA.
PMID: 34325022
J Sport Health Sci. 2021 Jul 27; doi: 10.1016/j.jshs.2021.07.007. Epub 2021 Jul 27.

OBJECTIVES: Although previous studies have examined the effects of exercise training on other International Classification of Functioning, Disability and Health (ICF) component levels in persons with multiple sclerosis (MS), the effects of exercise training on participation remain unclear. The...

Cite
Edwards T, Michelsen AS, Fakolade AO, et al. Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis. J Sport Health Sci. 2021;doi: 10.1016/j.jshs.2021.07.007.
Edwards, T., Michelsen, A. S., Fakolade, A. O., Dalgas, U., & Pilutti, L. A. (2021). Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis. Journal of sport and health science, . https://doi.org/10.1016/j.jshs.2021.07.007
Edwards, Thomas, et al. "Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis." Journal of sport and health science vol. (2021). doi: https://doi.org/10.1016/j.jshs.2021.07.007
Edwards T, Michelsen AS, Fakolade AO, Dalgas U, Pilutti LA. Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis. J Sport Health Sci. 2021 Jul 27; doi: 10.1016/j.jshs.2021.07.007. Epub 2021 Jul 27. PMID: 34325022.
Copy Download .nbib Format: NLM
Comparative risk of suicide by specific substance use disorders: A national cohort study.

Journal of psychiatric research

Crump C, Sundquist J, Kendler KS, Edwards AC, Sundquist K.
PMID: 34700213
J Psychiatr Res. 2021 Dec;144:247-254. doi: 10.1016/j.jpsychires.2021.10.017. Epub 2021 Oct 20.

Substance use disorders (SUDs) are important risk factors for suicide, yet little is known about how suicide risks vary by specific SUDs. We examined these risks for the first time in a large general population to facilitate comparisons across...

Cite
Crump C, Sundquist J, Kendler KS, et al. Comparative risk of suicide by specific substance use disorders: A national cohort study. J Psychiatr Res. 2021;144:247-254doi: 10.1016/j.jpsychires.2021.10.017.
Crump, C., Sundquist, J., Kendler, K. S., Edwards, A. C., & Sundquist, K. (2021). Comparative risk of suicide by specific substance use disorders: A national cohort study. Journal of psychiatric research, 144247-254. https://doi.org/10.1016/j.jpsychires.2021.10.017
Crump, Casey, et al. "Comparative risk of suicide by specific substance use disorders: A national cohort study." Journal of psychiatric research vol. 144 (2021): 247-254. doi: https://doi.org/10.1016/j.jpsychires.2021.10.017
Crump C, Sundquist J, Kendler KS, Edwards AC, Sundquist K. Comparative risk of suicide by specific substance use disorders: A national cohort study. J Psychiatr Res. 2021 Dec;144:247-254. doi: 10.1016/j.jpsychires.2021.10.017. Epub 2021 Oct 20. PMID: 34700213; PMCID: PMC8665134.
Copy Download .nbib Format: NLM
Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis.

Clinical journal of the American Society of Nephrology : CJASN

Rivara MB, Edwards T, Patrick D, Anderson L, Himmelfarb J, Mehrotra R.
PMID: 33785497
Clin J Am Soc Nephrol. 2021 Apr 07;16(4):588-598. doi: 10.2215/CJN.15570920. Epub 2021 Mar 30.

BACKGROUND AND OBJECTIVES: The population of patients with kidney failure in the United States using home dialysis modalities is growing rapidly. Unlike for in-center hemodialysis, there is no patient-reported experience measure for assessment of patient experience of care for...

Cite
Rivara MB, Edwards T, Patrick D, et al. Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis. Clin J Am Soc Nephrol. 2021;16(4):588-598doi: 10.2215/CJN.15570920.
Rivara, M. B., Edwards, T., Patrick, D., Anderson, L., Himmelfarb, J., & Mehrotra, R. (2021). Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis. Clinical journal of the American Society of Nephrology : CJASN, 16(4), 588-598. https://doi.org/10.2215/CJN.15570920
Rivara, Matthew B, et al. "Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis." Clinical journal of the American Society of Nephrology : CJASN vol. 16,4 (2021): 588-598. doi: https://doi.org/10.2215/CJN.15570920
Rivara MB, Edwards T, Patrick D, Anderson L, Himmelfarb J, Mehrotra R. Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis. Clin J Am Soc Nephrol. 2021 Apr 07;16(4):588-598. doi: 10.2215/CJN.15570920. Epub 2021 Mar 30. PMID: 33785497; PMCID: PMC8092066.
Copy Download .nbib Format: NLM
Anesthesia screen use may impact operating room communication practices in otolaryngology.

American journal of otolaryngology

Bourdillon AT, Mehra S, Rahmati R, Judson B, Edwards HA.
PMID: 33812208
Am J Otolaryngol. 2021 Sep-Oct;42(5):103000. doi: 10.1016/j.amjoto.2021.103000. Epub 2021 Mar 22.

OBJECTIVES: Failures in communication are a leading contributor to medical error. There is increasing attention on cultivating robust communication practices in the Operating Room (OR) to mitigate against patient injury and optimize efficient patient care. Few studies have evaluated...

Cite
Bourdillon AT, Mehra S, Rahmati R, et al. Anesthesia screen use may impact operating room communication practices in otolaryngology. Am J Otolaryngol. 2021;42(5):103000doi: 10.1016/j.amjoto.2021.103000.
Bourdillon, A. T., Mehra, S., Rahmati, R., Judson, B., & Edwards, H. A. (2021). Anesthesia screen use may impact operating room communication practices in otolaryngology. American journal of otolaryngology, 42(5), 103000. https://doi.org/10.1016/j.amjoto.2021.103000
Bourdillon, Alexandra T, et al. "Anesthesia screen use may impact operating room communication practices in otolaryngology." American journal of otolaryngology vol. 42,5 (2021): 103000. doi: https://doi.org/10.1016/j.amjoto.2021.103000
Bourdillon AT, Mehra S, Rahmati R, Judson B, Edwards HA. Anesthesia screen use may impact operating room communication practices in otolaryngology. Am J Otolaryngol. 2021 Sep-Oct;42(5):103000. doi: 10.1016/j.amjoto.2021.103000. Epub 2021 Mar 22. PMID: 33812208.
Copy Download .nbib Format: NLM
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.

The Journal of infection

Owen SI, Williams CT, Garrod G, Fraser AJ, Baldwin L, Brown L, Byrne RL, Collins AM, Cubas-Atienzar AI, de Vos M, Edwards T, Escadafal C, Ferreira DM, Fletcher T, Hyder-Wright A, Kay GA, Kontogianni K, Mason J, Menzies S, Mitsi E, Planche T, Sacks JA, Taylor J, Todd S, Tully C, Cuevas LE, Adams ER.
PMID: 34906597
J Infect. 2021 Dec 11; doi: 10.1016/j.jinf.2021.12.007. Epub 2021 Dec 11.

BACKGROUND: There are an abundance of commercially available lateral flow assays (LFAs) that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer, externally performed diagnostic accuracy studies to assess performance are essential. Herein we present an...

Cite
Owen SI, Williams CT, Garrod G, et al. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.007.
Owen, S. I., Williams, C. T., Garrod, G., Fraser, A. J., Baldwin, L., Brown, L., Byrne, R. L., Collins, A. M., Cubas-Atienzar, A. I., de Vos, M., Edwards, T., Escadafal, C., Ferreira, D. M., Fletcher, T., Hyder-Wright, A., Kay, G. A., Kontogianni, K., Mason, J., Menzies, S., Mitsi, E., Planche, T., Sacks, J. A., Taylor, J., Todd, S., Tully, C., Cuevas, L. E., & Adams, E. R. (2021). Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.007
Owen, Sophie I, et al. "Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.007
Owen SI, Williams CT, Garrod G, Fraser AJ, Baldwin L, Brown L, Byrne RL, Collins AM, Cubas-Atienzar AI, de Vos M, Edwards T, Escadafal C, Ferreira DM, Fletcher T, Hyder-Wright A, Kay GA, Kontogianni K, Mason J, Menzies S, Mitsi E, Planche T, Sacks JA, Taylor J, Todd S, Tully C, Cuevas LE, Adams ER. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. J Infect. 2021 Dec 11; doi: 10.1016/j.jinf.2021.12.007. Epub 2021 Dec 11. PMID: 34906597; PMCID: PMC8664720.
Copy Download .nbib Format: NLM
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts.

The American journal of psychiatry

Mallard TT, Savage JE, Johnson EC, Huang Y, Edwards AC, Hottenga JJ, Grotzinger AD, Gustavson DE, Jennings MV, Anokhin A, Dick DM, Edenberg HJ, Kramer JR, Lai D, Meyers JL, Pandey AK, Harden KP, Nivard MG, de Geus EJC, Boomsma DI, Agrawal A, Davis LK, Clarke TK, Palmer AA, Sanchez-Roige S.
PMID: 33985350
Am J Psychiatry. 2021 May 14;appiajp202020091390. doi: 10.1176/appi.ajp.2020.20091390. Epub 2021 May 14.

OBJECTIVE: Genome-wide association studies (GWASs) of the Alcohol Use Disorders Identification Test (AUDIT), a 10-item screen for alcohol use disorder (AUD), have elucidated novel loci for alcohol consumption and misuse. However, these studies also revealed that GWASs can be...

Cite
Mallard TT, Savage JE, Johnson EC, et al. Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts. Am J Psychiatry. 2021;appiajp202020091390doi: 10.1176/appi.ajp.2020.20091390.
Mallard, T. T., Savage, J. E., Johnson, E. C., Huang, Y., Edwards, A. C., Hottenga, J. J., Grotzinger, A. D., Gustavson, D. E., Jennings, M. V., Anokhin, A., Dick, D. M., Edenberg, H. J., Kramer, J. R., Lai, D., Meyers, J. L., Pandey, A. K., Harden, K. P., Nivard, M. G., de Geus, E. J. C., Boomsma, D. I., Agrawal, A., Davis, L. K., Clarke, T. K., Palmer, A. A., & Sanchez-Roige, S. (2021). Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts. The American journal of psychiatry, appiajp202020091390. https://doi.org/10.1176/appi.ajp.2020.20091390
Mallard, Travis T, et al. "Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts." The American journal of psychiatry vol. (2021): appiajp202020091390. doi: https://doi.org/10.1176/appi.ajp.2020.20091390
Mallard TT, Savage JE, Johnson EC, Huang Y, Edwards AC, Hottenga JJ, Grotzinger AD, Gustavson DE, Jennings MV, Anokhin A, Dick DM, Edenberg HJ, Kramer JR, Lai D, Meyers JL, Pandey AK, Harden KP, Nivard MG, de Geus EJC, Boomsma DI, Agrawal A, Davis LK, Clarke TK, Palmer AA, Sanchez-Roige S. Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts. Am J Psychiatry. 2021 May 14;appiajp202020091390. doi: 10.1176/appi.ajp.2020.20091390. Epub 2021 May 14. PMID: 33985350.
Copy Download .nbib Format: NLM
Differentiation of leucine and isoleucine residues in peptides using charge transfer dissociation mass spectrometry (CTD-MS).

Rapid communications in mass spectrometry : RCM

Edwards HM, Wu HT, Julian RR, Jackson GP.
PMID: 34927767
Rapid Commun Mass Spectrom. 2021 Dec 20;e9246. doi: 10.1002/rcm.9246. Epub 2021 Dec 20.

RATIONALE: The binding affinity of an antibody can be substantially altered by the replacement of Leu with Ile, and vice versa, so the ability to identify the correct isomer using mass spectrometric tools helps resolve important biological questions. Tandem...

Cite
Edwards HM, Wu HT, Julian RR, et al. Differentiation of leucine and isoleucine residues in peptides using charge transfer dissociation mass spectrometry (CTD-MS). Rapid Commun Mass Spectrom. 2021;e9246doi: 10.1002/rcm.9246.
Edwards, H. M., Wu, H. T., Julian, R. R., & Jackson, G. P. (2021). Differentiation of leucine and isoleucine residues in peptides using charge transfer dissociation mass spectrometry (CTD-MS). Rapid communications in mass spectrometry : RCM, e9246. https://doi.org/10.1002/rcm.9246
Edwards, Halle M, et al. "Differentiation of leucine and isoleucine residues in peptides using charge transfer dissociation mass spectrometry (CTD-MS)." Rapid communications in mass spectrometry : RCM vol. (2021): e9246. doi: https://doi.org/10.1002/rcm.9246
Edwards HM, Wu HT, Julian RR, Jackson GP. Differentiation of leucine and isoleucine residues in peptides using charge transfer dissociation mass spectrometry (CTD-MS). Rapid Commun Mass Spectrom. 2021 Dec 20;e9246. doi: 10.1002/rcm.9246. Epub 2021 Dec 20. PMID: 34927767.
Copy Download .nbib Format: NLM
Consensus statement: a framework for safe and effective intubation by paramedics.

British paramedic journal

Gowens P, Aitken-Fell P, Broughton W, Harris L, Williams J, Younger P, Bywater D, Crookston C, Curatolo L, Edwards T, Freshwater E, House M, Jones A, Millins M, Pilbery R, Standen S, Wiggin C.
PMID: 33328802
Br Paramed J. 2018 Jun 01;3(1):23-27. doi: 10.29045/14784726.2018.06.3.1.23.

This consensus statement provides profession-specific guidance in relation to tracheal intubation by paramedics - a procedure that the College of Paramedics supports. Tracheal intubation by paramedics has been the subject of professional and legal debate as well as crown...

Cite
Gowens P, Aitken-Fell P, Broughton W, et al. Consensus statement: a framework for safe and effective intubation by paramedics. Br Paramed J. 2018;3(1):23-27doi: 10.29045/14784726.2018.06.3.1.23.
Gowens, P., Aitken-Fell, P., Broughton, W., Harris, L., Williams, J., Younger, P., Bywater, D., Crookston, C., Curatolo, L., Edwards, T., Freshwater, E., House, M., Jones, A., Millins, M., Pilbery, R., Standen, S., & Wiggin, C. (2018). Consensus statement: a framework for safe and effective intubation by paramedics. British paramedic journal, 3(1), 23-27. https://doi.org/10.29045/14784726.2018.06.3.1.23
Gowens, Paul, et al. "Consensus statement: a framework for safe and effective intubation by paramedics." British paramedic journal vol. 3,1 (2018): 23-27. doi: https://doi.org/10.29045/14784726.2018.06.3.1.23
Gowens P, Aitken-Fell P, Broughton W, Harris L, Williams J, Younger P, Bywater D, Crookston C, Curatolo L, Edwards T, Freshwater E, House M, Jones A, Millins M, Pilbery R, Standen S, Wiggin C. Consensus statement: a framework for safe and effective intubation by paramedics. Br Paramed J. 2018 Jun 01;3(1):23-27. doi: 10.29045/14784726.2018.06.3.1.23. PMID: 33328802; PMCID: PMC7706753.
Copy Download .nbib Format: NLM
Showing 757 to 766 of 766 entries